Shockwave Therapy in Atherosclerosis: (LOJMS) - Lupine Publishers

Shockwave Therapy in Atherosclerosis by Michael AB Naafs* in LOJ Medical Sciences (LOJMS) in Lupine publishers

In this mini review recent developments in extracorporeal shockwave therapy (ESWT) within the field of atherosclerosis are discussed. Increased ecpression of growth factors such as endothelial nitric oxide (eNOS) and vascular endothelial growth factors(VGEFs) are induced by ESWT. IKL, integrin linked kinase, plays a key factor in this process of angiogenesis, believed to be responsible for the beneficial effects of ESWT. Both cardiac shock wave therapy (CWST) in chronic refractory angina pectoris patients as well as ESWT in patients with peripheral arterial disease (PAD) show a uniformly, consistent, beneficial effect in all studies available until now. International standardization of dose-response curves, doses applied, number of sessions and duration of treatment should be established at first, before starting large RCTs. With that knowledge the future of shockwave therapy in CAD and PAD seems bright in Lupine Publishers.

For more information click the below links

https://www.lupinepublishers.com/medical-science-journal/fulltext/shockwave-therapy-in-atherosclerosis.ID.000106.php
https://www.lupinepublishers.com/medical-science-journal/abstracts/shockwave-therapy-in-atherosclerosis.ID.000106.php
https://www.lupinepublishers.com/medical-science-journal/pdf/LOJMS.MS.ID.000106.pdf


For more Lupine Open Access journals click the below Linkhttps://www.lupinepublishers.com/

For more Medical Sciences Articles click the below Link
https://www.lupinepublishers.com/medical-science-journal/